Thred launches MVP App, one week after Microsoft event

Published 14-SEP-2016 09:57 A.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Unified social messaging software developer Thred Limited (ASX:THD) has announced the release of the Thred App in Minimum Viable Product (MVP) form.

The launch of the MVP app sees THD achieve Milestone 1 as set out in its recent prospectus.

The achievement was attained ahead of schedule and at a reduced cash burn rate than what was budgeted for in the ASX listing.

Following today’s positive news, THD is able to move forward towards Beta and global releases in the near future. With full commercialisation and continued integration to be carried out with first channel partner Microsoft.

As yet there is no set date for global release, so if considering THD for your portfolio seek professional financial advice for further information.

THD’s platform collates users’ contacts across existing messaging platforms and provides a single unified messaging hub, simplifying the communication process.

Users are able to communicate across various forms of social media and apps through a single interface offered by THD.

Thred MVP message centre with main feed, link and image sharing:

Connecting social media accounts and contacts with Thred:

In addition to today’s news, last week THD was invited by software giant Microsoft to showcase its unified social messaging platform that will be used in Microsoft Office 365.

THD was able to demonstrate its functionality across the platform to over 1,000 delegates and potential partners that were in attendance.

As a results of the Microsoft event THD is in talks with a number of potential partners, with an update to be announced to the market in due course should anything materialise from the discussions.

All investment decisions should be made with the aid of a financial expert, so please seek financial advice before making any investment decision. The information provided here should not be viewed as investment advice.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free